Company Profile

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC
BSE568.50-3.8 (-0.66 % )
PREV CLOSE (Rs.) 572.30
OPEN PRICE (Rs.) 572.35
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 907
TODAY'S LOW / HIGH (Rs.)561.95 573.50
52 WK LOW / HIGH (Rs.)406.65 604.55
NSE569.40 -2.25 (-0.39 % )
PREV CLOSE(Rs.) 571.65
OPEN PRICE (Rs.) 574.30
BID PRICE (QTY) 569.40 (10 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 10815
TODAY'S LOW / HIGH(Rs.) 559.95 574.30
52 WK LOW / HIGH (Rs.)407.15 604.7

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 5.15694
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 25.75
ROCE (%) 32.41
Incorporation Year : 2000

Management Info :

A Velumani - Chairman A Velumani - Managing Director

Registered Office :

Address : D - 37/1, Ttc Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone : 022 2762 2762

Website : www.thyrocare.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
07Dec12-07-2019$Thyrocare Technologies informs about analyst meetings Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about forthcoming Analyst Meetings. The Company will meet with the representative(s) of Banyan Capital Advisors LLP, at 11.30 A.M. on Monday, December 09, 2019; representative(s) of PhillipCapital (India), at 03.30 P.M. on Wednesday, December 11, 2019; representative(s) of Arisaig Partners, at 11.00 A.M. on Monday, December 16, 2019; and representative(s) of Spark Capital Advisors (I), at 11.00 A.M. on Tuesday, December 17, 2019, to be followed by a visit by them to its lab.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
08Nov11-08-2019$ Board declares Interim Dividend Board declares Interim Divi
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 07, 2019, inter alia, have approved payment of interim dividend for the financial year 2019-20, at the rate of Rs. 5.00 (Rupees Five only) per share (50% of the face value of Rs. 10/- each).
Thyrocare Technologies Ltd has informed BSE that the Board of D..
08Nov11-08-2019$ Corporate Action - Fixing Of Record Date For Interim Dividend 2019-20











Corporate Action - Fixing O
Please refer to our letter dated 07-11-2019 communicating the outcome of the Board Meeting held yesterday, wherein we had intimated to you that the Board of Directors of the Company have declared an Interim Dividend of Rs. 5/- (Rupees five only) Per Share for the Financial Year 2019-20. Please note that Friday, 22nd November 2019, has been fixed as the record date for the purpose of determining the eligibility of shareholders for the interim dividend as above.
Please refer to our letter dated 07-11-2019 communicating the o..
20Sep09-20-2019$Thyrocare Technologies to consider report of valuation of wholly owned subsidiary Thyrocare Technologies to co

Thyrocare Technologies is going to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the company's shareholding in NHL or dispose it. The meeting of the Board of Directors of the company will be held on September 21, 2019, to consider the same. 

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.

Thyrocare Technologies is going to consider the report of valua..
12Aug08-12-2019$Thyrocare Technologies informs about quarterly results presentation Thyrocare Technologies infor

Thyrocare Technologies has informed about copy of Presentation on Quarterly Results of the company for the quarter ended 30-06-2019. This is only uploaded in its website, and has not been distributed or advertised in newspapers or otherwise publicised.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Technologies has informed about copy of Presentation..
Financials More
Rs. in Millions
QTR Sep 19 ANNUAL 19
Net Profit374.3952.3
Gross Profit 484.3 1468.6
Operating Profit 540.81618
Net Sales 1078.93702.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kovai Medical Center (BSE)
 769.60 (1.49%)
M.Cap ( in Cr)
842.12
Tejnaksh Healthcare (BSE)
 59.85 (5.00%)
M.Cap ( in Cr)
60.79
NG Industries (BSE)
 58.80 (3.43%)
M.Cap ( in Cr)
19.70
Lotus Eye Hospital (BSE)
 22.70 (2.48%)
M.Cap ( in Cr)
47.21
KMC Speciality Hosp (BSE)
 13.43 (1.97%)
M.Cap ( in Cr)
219.02
Shareholding Pattern More
NON-INSTITUTION 8.42 %
PROMOTERS 66.06 %
MUTUAL FUNDS/UTI 14.31 %
FI/BANKS/INSURANCE 0.45 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes